Cannabis Law Report

MARCH 18, 2021

Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.

Pharmaceutical 98

Pharmaceutical Cannabis 98

Cannabis Law Report

MAY 12, 2021

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More.

Pharmaceutical 75

Pharmaceutical Business 75

Cannabis Law Report

JANUARY 17, 2023

Celadon Pharmaceuticals PLC shares rose on Monday after the company said that its Midlands facility has been registered for the good manufacturing practice standard by the U.K.’s The UK-based pharmaceutical company focused on […]. ’s health watchdog for the production of its medicinal cannabis. pence, or 11%, at 57.0

Pharmaceutical 52

Pharmaceutical Medicine Cannabis 52

Cannabis Law Report

MAY 12, 2020

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

Pharmaceutical 98

Pharmaceutical Cannabinoids 98

Cannabis Law Report

AUGUST 10, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. About MyMD Pharmaceuticals, Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

United Patients Group

MARCH 15, 2023

The post Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs? Remember to consult or discuss this with your doctor or medical professional before starting to titrate off your medications. appeared first on United Patients Group.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Medical Marijuana Program Connection

APRIL 23, 2024

According to GlobalData’s company profile on Jazz Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. Jazz Pharmaceuticals‘s grant share as of February 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents. Cbd preparation with at least.

Pharmaceutical 40

Pharmaceutical CBD THC Treatment 40

Cannabis Law Report

JANUARY 23, 2023

VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court. The insolvency declaration judgment, requested by one of the company’s more than 80 creditors, was handed down on 23 November 2022 and has now become final, in January 2023.

Pharmaceutical 52

Pharmaceutical Access Cannabis Compliance 52

Cannabis Law Report

FEBRUARY 3, 2021

The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report.

Pharmaceutical 98

Pharmaceutical Law Cannabis 98

Medical Marijuana Program Connection

FEBRUARY 13, 2024

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates Source link. Read More

Pharmaceutical 64

Pharmaceutical Business 64

Cannabis Law Report

MAY 26, 2023

Multinational operator to supply pharmaceutical-grade CBD extract for European patients TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc.

Pharmaceutical 52

Pharmaceutical Extraction Medicine CBD 52

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Medical Marijuana Program Connection

NOVEMBER 14, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates Source link. Read More

Pharmaceutical 69

Pharmaceutical Business 69

Cannabis Law Report

JUNE 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

Cannabis Law Report

OCTOBER 25, 2022

The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. The company signed a definitive agreement with Franchise Global Health, which has principal operations in Europe’s largest economy.

Pharmaceutical 59

Pharmaceutical Cannabis 59

Medical Marijuana Program Connection

OCTOBER 6, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) (“Anebulo”), today announced. Read More

Pharmaceutical 64

Pharmaceutical Cannabinoids Business 64

Cannabis Law Report

MARCH 20, 2021

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

Pharmaceutical 98

Pharmaceutical Programs Cannabis 98

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

FEBRUARY 3, 2021

The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report.

Pharmaceutical 98

Pharmaceutical Law Cannabis 98

Cannabis Law Report

OCTOBER 20, 2020

Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More. The post Prohibition Partners (UK) Publish "The Pharmaceutical Cannabis Report" first appeared on Cannabis Law Report.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis Law 59

Cannabis Law Report

FEBRUARY 3, 2021

The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report.

Pharmaceutical 85

Pharmaceutical Law Cannabis 85

Cannabis Law Report

MAY 6, 2021

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More.

Pharmaceutical 59

Pharmaceutical Business 59

Cannabis Law Report

APRIL 13, 2021

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis 59

Cannabis Law Report

MARCH 26, 2022

Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. ” ‘Strategic investment’ Jazz Pharmaceuticals currently manufactures the extract, active pharmaceutical ingredients and the formulated drug products at KSP, occupying 12 buildings with more than 400 employees.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. Eastern time on the Investors section of Anebulo’s website. Scott Anderson.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Business 52

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Medical Marijuana Program Connection

MAY 12, 2023

–(BUSINESS WIRE)– #pharma–Summary: Virpax Pharmaceuticals to Present at Upcoming CB Tech Watch Seminar Source link. BERWYN, Pa.–(BUSINESS Read More

Pharmaceutical 40

Pharmaceutical Business 40

Cannabis Law Report

MAY 31, 2023

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Patients 52

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. Eurofins is a global leader in food, environment, and pharmaceutical product testing.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Medical Marijuana Program Connection

FEBRUARY 13, 2024

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.®

Pharmaceutical 49

Pharmaceutical Therapy Conditions Business 49

Cannabis Law Report

DECEMBER 12, 2020

Clever Leaves expands global capabilities and development of market specific pharmaceutical products. The post Clever Leaves Successfully Delivers First Shipment of EU GMP certified Cannabis derived Pharmaceuticals from Colombia to Germany first appeared on Cannabis Law Report. NEW YORK, Dec.

Pharmaceutical 84

Pharmaceutical Law Cannabis 84

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Medical Marijuana Program Connection

JANUARY 31, 2023

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More

Pharmaceutical 52

Pharmaceutical Business 52

Medical Marijuana Program Connection

MARCH 2, 2023

MyMD Pharmaceuticals, Inc. MYMD announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational. Read More

Pharmaceutical 52

Pharmaceutical DEA CBD 52

Medical Marijuana Program Connection

JANUARY 18, 2023

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More.

Pharmaceutical 52

Pharmaceutical Business 52

Medical Marijuana Program Connection

FEBRUARY 19, 2024

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Industry in South Africa 2023” report has been added to ResearchAndMarkets.com’s offering. More than 80% of South African pharmaceutical manufacturing and distribution revenue is from the private sector.

Pharmaceutical 45

Pharmaceutical Business 45

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98